Gritstone bio Inc
NASDAQ:GRTS
Gritstone bio Inc
NASDAQ:GRTS
Price:
0.9627 USD
10.66%
Market Closed
Updated:
May 5, 2024
Gritstone bio Inc
Cash from Financing Activities
|
Gritstone bio Inc
Cash from Financing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gritstone bio Inc
NASDAQ:GRTS
|
Cash from Financing Activities
$25.1m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$17.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
$21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$562.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
See Also
What is Gritstone bio Inc's Cash from Financing Activities?
Cash from Financing Activities
25.1m
USD
25.1m
USD
Based on the financial report for Dec 31, 2023, Gritstone bio Inc's Cash from Financing Activities amounts to 25.1m USD.
What is Gritstone bio Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-26%
-26%
Over the last year, the Cash from Financing Activities growth was -70%. The average annual Cash from Financing Activities growth rates for Gritstone bio Inc have been -43% over the past three years , -26% over the past five years .
You don't have any saved screeners yet
